Medical Science Liaison Oncology Poland

Join to apply for the Medical Science Liaison Oncology Poland role at Menarini Stemline Medical Science Liaison Oncology, Poland Reports to Medical Head Oncology, CEE Menarini Stemline is hiring a Medical Science Liaison Oncology. The Medical Science Liaison (MSL) will be responsible for the scientific exchange of Stemline’s pipeline, disease state awareness and general scientific discussions of data with Key Opinion Leaders (KOLs) and Health Care Providers (HCPs). The MSL will represent Stemline in the support of research interest with both Company Sponsored Trials and Investigator Initiated Research. MSLs provide medical information through scientific exchange in a fair and balanced manner and provide clinical/scientific support. The MSL will also support the safety education to HCPs and allied health professionals for the use of Stemline products. Responsibilities Identify key opinion leaders and establish, foster, cultivate, and maintain relationships with healthcare providers (HCPs) in academic and community centres within assigned territory including but not limited to clinical investigators, national and regional opinion leaders and speakers. Develop and execute territory plans in alignment with EMEA, CEE and global Medical Affairs strategies. Provide insights/feedback on emerging scientific/clinical data that enhance the value and appropriate use of Stemline products as part of compliant collaboration with internal stakeholders. Give medical/scientific presentations to internal and external groups. Present appropriate clinical and scientific information to healthcare providers in response to unsolicited requests (as appropriate) in a fair and balanced manner. Liaise with academic research institutions to address medical and scientific inquiries, facilitate investigator-initiated clinical trials and support company-sponsored clinical trials. Assist in the development of medical communications materials and publications. Act as the primary point of contact and facilitator for all aspects of investigator-sponsored trials (ISTs), from submission, review and approval, through study activation/completion. In collaboration with medical and clinical operations teams, support Stemline-sponsored trials through trial site recommendations and raising awareness of the trials and accrual timelines. Serve as scientific resource to commercial partners, as appropriate, to support activities. Support the execution, organization, and planning of advisory boards. Professionally represent Stemline at select medical and scientific conferences and meetings. Sustain expertise in therapeutic area treatment management and new therapies, competitive products and features, and provide feedback to the senior leadership team on specific initiatives. Provide local support on complaints, medical support, market access, pricing, and reimbursement processes if needed. Skills/Knowledge Advanced degree preferred: (MD, PhD, PharmD preferred). At least 5 years of MSL experience preferred. At least 2 years MSL/Medical Affairs experience in Hematology & Oncology/Solid Tumor focus preferred, experience in breast cancer is an advantage. Strong knowledge and/or experience of healthcare and access environments. High internal motivation, proactive working habits and a positive mindset. Proven ability to work independently, as well as cross-functionally with numerous internal stakeholders in a high-matrixed environment, including joint venture collaborations. Preferred experience on product launches or demonstrated success as product or therapeutic point. Excellent interpersonal communication and presentation skills, strong personal integrity, teamwork abilities, and a customer focus are necessary. Must be able to organize, prioritize, and work effectively in a constantly changing environment. Strong compliance knowledge and adherence to corporate compliance policies. Current working knowledge of EFPIA (INFARMA) and other compliance regulations and guidelines relevant to industry interactions with healthcare professionals. Demonstrated technical acumen including MS Office skills, ability to adopt and leverage multiple business applications. This position will require greater than 75% domestic travel, including within the territory, and to the home office and national meetings. The Company Founded in 1886 in Naples as Farmacia Internazionale, Menarini moved to Florence in 1915, where its headquarters remain. The company’s foundation is built on five pillars: high-quality therapeutics, ethics, innovation, people-centricity, and environmental sustainability. Menarini is an Italian pharmaceutical company with nearly 135 years of history. Present in 70 countries, Menarini’s products are sold in 140 locations worldwide. Its presence spans Europe, Asia, Africa, the Middle East, Central America, and the U.S., where its acquisition of Stemline Therapeutics marked entry into the U.S. oncology market. With the contribution of about 18,000 employees, over 500 million drug packs are produced annually at 18 manufacturing sites, including a biotech plant for monoclonal antibodies serving clients across six continents. Menarini has made significant investments in oncology, with a pipeline of five investigational compounds for treating hematological and solid tumors. The acquisition of Stemline Therapeutics in June 2020 strengthened its oncology portfolio, including commercial and clinical-stage assets. Tagraxofusp, a novel first-in-class therapy, is approved for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in the U.S. and EU. It’s also being explored for other indications, including acute myeloid leukemia (AML) and chronic myelomonocytic leukemia (CMML). Menarini holds exclusive commercialization rights to Selinexor for oncology indications in the EU, Latin America, and other key countries. Selinexor is a first-in-class oral therapy for hematologic cancers and solid tumors. Menarini has also partnered with Radius Health to develop Elacestrant, an oral SERD for hormone receptor-positive advanced breast cancer, with a positive Phase 3 study and FDA approval in 2023. Menarini’s commitment to oncology extends to liquid biopsy diagnostics through Menarini Silicon Biosystems (MSB), a leader in rare cell analysis. MSB’s CELLSEARCH Circulating Tumor Cell (CTC) Test is FDA‑cleared for detecting and counting CTCs in metastatic breast, prostate, and colorectal cancers. MSB offers non‑invasive Laboratory Developed Tests (LDTs) in the U.S., including CMC enumeration, CTC enumeration, and PDL‑1/HER2 biomarker tests. In 2022, MSB launched the CELLSEARCH® Circulating Multiple Myeloma Cell (CMMC) Enumeration LDT, which helps assess plasma cell burden without bone marrow biopsies. Menarini’s vision in oncology is to combine innovative therapies and advanced liquid biopsy diagnostics for more precise patient management. It’s an exciting time for the company, offering great opportunities for those joining the team. Menarini Stemline is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. Seniorities Seniority level Mid‑Senior level Employment type Employment type Full‑time Job function Job function Product Management and Research Industries Biotechnology and Pharmaceutical Manufacturing #J-18808-Ljbffr